Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
Videos
Keck School of Medicine of USC
Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to Do It and Why
FEATURING
Howard Liebman
- 172 views
- August 30, 2024
- 1
Keck School of Medicine of USC
CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients With Cold Agglutinin Disease
FEATURING
Ilene Weitz
- 158 views
- May 23, 2024
Keck School of Medicine of USC
Eltrombopag in the Treatment of ITP
FEATURING
Howard A. Liebman
- 192 views
- March 23, 2022
- 1
Keck School of Medicine of USC
1L Nivo + Low-Dose Ipi for MSI-H/dMMR mCRC: CheckMate 142 Highlights
FEATURING
Heinz-Josef Lenz
- 120 views
- October 28, 2021
- 1
Keck School of Medicine of USC
FDA Approval for Pegcetacoplan as Treatment for Paroxysmal Nocturnal Hemoglobinuria
FEATURING
Ilene Weitz
- 286 views
- September 14, 2021
Keck School of Medicine of USC
Optimizing Treatment of AFib: What Drugs Are Recommended in ACA/AHA/HRS Guidelines? When to Perform RF Catheter Ablation?
FEATURING
Anil Bhandari
- 941 views
- February 12, 2021
- 5
Keck School of Medicine of USC
Stroke Prevention in AFib: Should You Perform LAA Closure or Prescribe Warfarin?
FEATURING
Ivan Ho
- 228 views
- February 12, 2021
Keck School of Medicine of USC
Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to Use and Which Should Be Avoided?
FEATURING
Helga Van Herle
- 540 views
- February 11, 2021
- 8
Keck School of Medicine of USC
Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?
FEATURING
Steven Nissen
- 947 views
- January 5, 2021
- 13
Keck School of Medicine of USC
Newer Therapies in Management of Chronic Heart Failure: Roles of SGLT2 Inhibitors and Vericiguat
FEATURING
Kruti Pandya
- 290 views
- December 28, 2020
Keck School of Medicine of USC
Can Diets Help Treat ADPKD?
FEATURING
Thomas Weimbs
- 196 views
- December 18, 2020
- 2
Keck School of Medicine of USC
Amyloidosis & Kidney Disease: What Are the New Advances in Diagnosis & Management?
FEATURING
Miroslaw Smogorzewski
- 600 views
- December 17, 2020
- 1
Keck School of Medicine of USC
31 y/o With IgG4-Related Kidney Disease: How to Treat IgG4-RKD With Systemic Epstein-Barr Virus Infection?
FEATURING
Yan Zhong
- 190 views
- December 17, 2020
- 2
Keck School of Medicine of USC
TAME-PKD 2020 Trial Review on Metformin in ADPKD: How Tolerable and Safe Is It?
FEATURING
Ronald D. Perrone
- 266 views
- December 17, 2020
Keck School of Medicine of USC
Polycystic Kidney Disease: What Are the New Signaling Pathways and Possible Therapeutic Targets?
FEATURING
Michael Kaplan
- 435 views
- December 17, 2020
- 3
Keck School of Medicine of USC
2020 Update on ADPKD Treatment: What Are the Novel Drug Candidates, and Why Are They Promising?
FEATURING
Kenneth R. Hallows
- 600 views
- December 17, 2020
- 3
Keck School of Medicine of USC
Polycystic Kidney Disease: What Is the Efficacy of Tolvaptan, and How Does It Compare to Other Renal Protective Therapies?
FEATURING
Neera Dahl
- 2,026 views
- December 17, 2020
- 11